-
Bladder Cancer
821
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Urology2023-05-22 20:00:00
Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Non-Small Cell Lung Cancer
3004986
us
1
0.5
9
0.5
0.5
Roundtable
0
1
General Surgery2023-05-03 20:00:00
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Melanoma
65
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-04-20 20:00:00
Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Acute Pain
5000003
global
1
0.5
9
0.5
2
0.5
0.5
Roundtable
0
1
Anesthesiology2023-04-13 20:00:00
Have you heard about the new practice guidelines on monitoring and antagonism of NMB?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.75
9
0.75
2
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-28 20:00:00
What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-26 20:00:00
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Diverticular Disease
3003530
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
1
Gastroenterology2023-06-01 20:00:00
Elective sigmoid resection for recurrent or painful diverticulitis should be considered, using shared decision-making with the patient.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Bladder Cancer
821
global
1
1.25
9
1.25
1.25
Roundtable
0
1
Urology2023-05-22 20:00:00
Did you know that immunotherapy-based regimens are being used to treat patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC) leading to improved outcomes?
1.25ABIM MOC
1.25CME/CE
75MIN
Save
-
Skin and Soft Tissue Infection
3029299
global
1
1.0
9
1.0
1.0
Journal Article
0
1
Infectious Diseases2023-05-17 20:00:00
A case series of Francisella tularensis-related prosthetic joint infection supports surgical treatment with long-term antibiotics.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Non-Small Cell Lung Cancer
3004986
us
1
0.5
9
0.5
0.5
Roundtable
0
1
General Surgery2023-05-03 20:00:00
The complexity of treatment has increased dramatically; how effectively are you communicating with your patients?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Acute Pain
5000003
global
1
0.5
9
0.5
0.5
Clinical Brief
0
1
Internal Medicine2023-04-24 20:00:00
A show code, even with patient/family consent, undermines patient autonomy, patient-physician relationships, and professional integrity.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Melanoma
65
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-04-20 20:00:00
Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Acute Pain
5000003
global
1
0.5
9
0.5
2
0.5
0.5
Roundtable
0
1
Anesthesiology2023-04-13 20:00:00
Have you heard about the new practice guidelines on monitoring and antagonism of NMB?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.75
9
0.75
2
0.75
0.75
Roundtable
0
1
Hematology-Oncology2023-03-28 20:00:00
What do the guidelines say about treating patients with early breast cancer at high risk for recurrence?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-26 20:00:00
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Inflammatory Bowel Disease
3032545
global
1
1.0
1.0
Clinical Review
0
1
Gastroenterology2023-03-22 20:00:00
Dr. Parambir Dulai discusses new therapies and treatments for IBD, as well as what is on the horizon for IBD patients.
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Breast Cancer
840
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-20 20:00:00
Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
0
global
1
1.0
1.0
Clinical Case
0
1
Dermatology2023-03-09 19:00:00
What would you do if your patient had painful abscesses and skin nodules?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Head and Neck Cancer
3004984
global
1
1.0
9
1.0
2
1.0
1.0
Clinical Review
0
1
Hematology-Oncology2023-03-09 19:00:00
Did you know that targeted agents and immunotherapies are improving outcomes in patients with low-grade and high-grade brain tumors?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Melanoma
65
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-08 19:00:00
Do you know the role of lymphocytic activation gene 3 (LAG3) in metastatic melanoma and its potential as a treatment target?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Lung Cancer
5000186
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-02-27 19:00:00
Do you know the latest information on immunotherapy for the management of non-small cell lung cancer (NSCLC)?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Aesthetic Medicine
5000574
global
1
0.5
2
0.5
0.5
Roundtable
0
1
General Surgery2023-02-26 19:00:00
Chemical peeling can yield great results in skin rejuvenation; our experts explain what you need to know to start peeling in your own practice.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Biologic Therapy
5000033
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-02-22 19:00:00
Did you know? Immunotherapy is now being used for the neoadjuvant and adjuvant treatment of solid tumors -- find out more here!
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Glioblastoma
1541
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-02-21 19:00:00
A 65-year-old patient, John, presents with rapid, progressive left-sided weakness. You suspect glioblastoma. What would you do next?
0.25ABIM MOC
0.25CME/CE
15MIN
Save